Clinical Trials Sponsored by Ferring SAU

Total 12305 results

Ferring Pharmaceuticals

Completed

One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population (PANDA)

Prostate Cancer

China
Ferring Pharmaceuticals

Completed

Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (BASIC)

Infertility

Belgium, Spain, Australia, Canada, Czech Republic, Poland
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) (DELUTS)

Lower Urinary Tract Symptoms (LUTS)

United States, Canada, Belgium, Czech Republic, Italy, Poland
Ferring Pharmaceuticals

Completed

Efficacy and Safety of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding

United States
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Patients With Prostate Cancer

Prostate Cancer

United States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
Ferring Pharmaceuticals

Completed

Menopur Mixed Protocol (COMBINE)

Infertility

United States
Ferring Pharmaceuticals

Completed

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Induction of Labor | Cervical Ripening

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy

Cervical Priming

United States
Ferring Pharmaceuticals

Completed

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer (IM1)

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Ulcerative Colitis

Czech Republic
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women (NOC)

Nocturia

Japan
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Patients With Nocturia

Nocturia

Czech Republic
Ferring Pharmaceuticals

Completed

Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

Crohn's Disease

United States
Ferring Pharmaceuticals

Completed

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding (PREA)

Menorrhagia

United States
Ferring Pharmaceuticals

Completed

Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo (NOC)

Nocturia

Japan
Ferring Pharmaceuticals

Completed

MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer (MEGASET)

Infertility

Turkey, Belgium, Spain, Poland, Czech Republic, Denmark, Sweden
Ferring Pharmaceuticals

Completed

Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

Infertility, Female

Belgium, Czech Republic, Spain
Ferring Pharmaceuticals

Terminated

Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

Prostate Cancer
Ferring Pharmaceuticals

Completed

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

Turner's Syndrome

Czech Republic, France, Netherlands
Ferring Pharmaceuticals

Completed

Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC

Osteoarthritis

United States
Ferring Pharmaceuticals

Completed

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)

Primary Nocturnal Enuresis

France
Ferring Pharmaceuticals

Completed

A Study of Pentasa in Patients With Ulcerative Colitis

Ulcerative Colitis

Czech Republic
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Prostate Cancer

Korea, Republic of
University of California, San Francisco
Ferring Pharmaceuticals

Completed

To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection

Knee Osteoarthritis

United States
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Prostate Cancer

Korea, Republic of
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Ferring Pharmaceuticals

Recruiting

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States (ABLE-41)

Bladder Cancer

United States
Ferring Pharmaceuticals

Recruiting

REBYOTA™ Prospective Registry (ROAR)

Recurrence of Clostridium Difficile Infection

United States
Ferring Pharmaceuticals

Recruiting

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan
Ferring Pharmaceuticals

Recruiting

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PICCOLO)

Bowel Preparation

United States
Ferring Pharmaceuticals

Completed

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (BEYOND)

Infertility, Female

Norway, Israel, Denmark, Netherlands, Italy, Austria, Switzerland
Ferring Pharmaceuticals

Completed

Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease (PROGNOS)

Crohn's Disease

Germany
Ferring Pharmaceuticals

Terminated

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (MERMAID)

Preterm Delivery | Inadequate Milk Production

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
Ferring Pharmaceuticals

Completed

Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

Infertility, Female

Korea, Republic of
Ferring Pharmaceuticals

Completed

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer

Prostate Cancer

United Kingdom
Ferring Pharmaceuticals

Completed

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia) (NOC01)

Nocturia Due to Nocturnal Polyuria

Japan
Ferring Pharmaceuticals

Completed

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population (MEGASET HR)

Infertility

United States
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (RAINBOW)

Controlled Ovarian Stimulation

United Kingdom, Denmark, Belgium, Czechia, Spain
Ferring Pharmaceuticals

Completed

Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis (QLARITY)

Endometriosis

Germany, Poland, Denmark, Italy
Ferring Pharmaceuticals

Completed

An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer (PandaExtension)

Prostate Cancer

China
Ferring Pharmaceuticals

Completed

General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

Pregnancy | Cervical Ripening

Japan
Ferring Pharmaceuticals

Completed

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Nocturnal Polyuria

United States
Ferring Pharmaceuticals

Completed

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures (PROFILE)

Controlled Ovarian Stimulation

Australia, Austria, Belgium, Canada, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Infertility, Female

China
Ferring Pharmaceuticals

Completed

MEDAM (Menopur Retrospective Data prograM) (MEDAM)

Infertility, Female

France
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Terminated

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial (SEPSIS-ACT)

Septic Shock

United States, Belgium, Denmark, France, Netherlands

3

Subscribe